Health Care

Merck Reports Better Than Expected 3Q Earnings

Dow component Merck reported an adjusted 3Q profit of $1.07 per share, topping the estimate for $0.99. Revenue for the drugmaker came in at $10.54 billion, also beating the estimate for $10.17 billion

Novartis profit slips as key drug goes generic

Swiss drug company Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.

3 Stupid Medicare Moves

Boneheaded moves can really set you back. Be smart about Medicare and you can improve both your physical and fiscal condition.